Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systemic but not intraocular Epo Gene Transfer Protects the Retina from Light-and Genetic-Induced Degeneration

27 Aug 2004

Abstract excerpt

Molecules with neurotrophic activity are being evaluated for treatment of retinitis pigmentosa in animal models. In particular, great interest has been focused recently on erythropoietin (Epo). Evidence of its neurotrophic activity comes mainly from data demonstrating photoreceptor protection in a rodent light-damage model through systemic administration of a recombinant form of this hormone. Our goal was to test...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Erythropoietin and Anemia Treatment
Share to Retinal Development and Disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15509503
DOI: 10.1016/j.ymthe.2004.07.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systemic but not intraocular Epo Gene Transfer Protects the Retina from Light-and Genetic-Induced DegenerationPMID 15509503Read ↗

Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration.Semantic proximity Read ↗

Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration.Semantic proximity Read ↗

Amelioration of Photoreceptor Degeneration by Intravitreal Transplantation of Retinal Progenitor Cells in RatsSemantic proximity Read ↗

Systemic Adeno-Associated Virus-Mediated Gene Therapy Preserves Retinal Ganglion Cells and Visual Function in DBA/2J Glaucomatous MiceSemantic proximity Read ↗

Erythropoietin — An Endogenous Retinal Survival FactorSemantic proximity Read ↗

Neuroprotective Strategies for the Treatment of Inherited Photoreceptor DegenerationSemantic proximity Read ↗

Two Animal Models of Retinal Degeneration Are Rescued by Recombinant Adeno-associated Virus-Mediated Production of FGF-5 and FGF-18Semantic proximity Read ↗

Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage.Semantic proximity Read ↗

Pigment Epithelium-Derived Factor Gene Therapy Targeting Retinal Ganglion Cell Injuries: Neuroprotection against Loss of Function in Two Animal ModelsSemantic proximity Read ↗

Pigment Epithelium-Derived Factor, a Protective Factor for Photoreceptors in Vivo.Semantic proximity Read ↗

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.Semantic proximity Read ↗

What should a clinician know to be prepared for the advent of treatment of retinal dystrophies?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.